Histosonics Announces $100 Million In Financings And New Appointment To Its Board Of Directors
Amount Raised
$100 Million
Round Type
Funding Round
MinneapolisHealthcareInvestors
Description
HistoSonics, Inc. (www.histosonics.com), the developer of a non-invasive, novel sonic beam therapy, announced today that it has raised $85 million in a financing led by Johnson & Johnson Innovation - JJDC, Inc., with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others. Concurrently, HistoSonics also secured a commitment for a $15 million expansion of the amount available under its existing debt facility with Signature Bank, which the company may access to accelerate strategic projects. Proceeds of the financings will be used to support HistoSonics anticipated commercial launch, additional clinical trials, and to expand application development of EdisonTM, the company's novel histotripsy therapy platform, throughout the body.
Quick answer
HistoSonics raised $100 Million in a Funding Round round, dated December 13, 2022. Investors: State Of Wisconsin Investment Board, Yonjin Venture and Lumira Ventures. HistoSonics is based in Minneapolis, Minnesota, United States.
- How much did HistoSonics raise?
- HistoSonics raised $100 Million in a Funding Round round on December 13, 2022.
- Who invested in HistoSonics?
- State Of Wisconsin Investment Board, Yonjin Venture and Lumira Ventures are named as investors in this round.
- What does HistoSonics do?
- HistoSonics is a growth phase company developing a non-invasive sonic beam therapy platform and procedure using the science of histotripsy.
- Where is HistoSonics based and how big is it?
- HistoSonics is based in Minneapolis, Minnesota, United States. Fundz records about 280 employees.
- Who are the decision-makers at HistoSonics?
- Fundz holds 2 contacts at HistoSonics, including the Area Sales Director - Northeast U.S. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as HistoSonics that raised within 45 days of this round, from Fundz verified event records.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- Persona Health raised $25K (Pre-Seed) on January 27, 2023.
- WETHRIVV raised $650K (Seed) on January 27, 2023.
- Remedy Diagnostics raised $345K (Seed) on January 27, 2023.
- ADARx Pharmaceuticals, Inc. raised $46M on January 26, 2023.
- Accure Acne raised $8M on January 26, 2023.
Who to call at HistoSonics, and when
A new round usually means HistoSonics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HistoSonics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HistoSonics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HistoSonics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HistoSonics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HistoSonics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.